Download PDF

Other users also viewed these articles

Risk factors for developing hepatocellular carcinoma in patients treated with direct-acting antivirals I. Santana-Salgado, A. Bautista-Santos, R. Moreno-Alcántar
10.1016/j.rgmxen.2021.09.005
Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources S. Marciano, L. Haddad, S.M. Borzi, C. D’Amico, L.A. Gaite, M.V. Aubone, M.E. Sirotinsky, N. Ratusnu, M.S. Frola, M.C. Aparicio, B. Ríos, M.N. Anselmo, R. Hansen, S. De Filippi, C. García Dans, L. de Labra, M.A. Peche, T.M. Strella, M. Ibáñez Duran, M.B. García Rosales, M. Dirchwolf, O.A. Galdame, A.C. Gadano
10.1016/j.rgmxen.2018.05.013
Hepatitis C virus genotype 5 in Mexico: A case report with successful treatment and a literature review Rubio-Lezama, López-Alférez, Santillán-Arreygue, Romero-Figueroa